Carillon Tower Advisers Inc. Sells 94,249 Shares of Canada Goose Holdings Inc (NYSE:GOOS)

Share on StockTwits

Carillon Tower Advisers Inc. reduced its stake in shares of Canada Goose Holdings Inc (NYSE:GOOS) by 5.5% in the third quarter, according to its most recent filing with the SEC. The fund owned 1,632,528 shares of the company’s stock after selling 94,249 shares during the period. Carillon Tower Advisers Inc. owned approximately 1.49% of Canada Goose worth $71,782,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Kistler Tiffany Companies LLC bought a new stake in shares of Canada Goose during the 2nd quarter worth $29,000. Steward Partners Investment Advisory LLC bought a new stake in Canada Goose in the second quarter worth $52,000. Valeo Financial Advisors LLC lifted its stake in Canada Goose by 2,700.0% in the second quarter. Valeo Financial Advisors LLC now owns 2,100 shares of the company’s stock worth $81,000 after purchasing an additional 2,025 shares during the last quarter. Pathstone Family Office LLC bought a new stake in Canada Goose in the second quarter worth $112,000. Finally, Stonehage Fleming Financial Services Holdings Ltd bought a new stake in Canada Goose in the second quarter worth $116,000. 51.20% of the stock is owned by institutional investors.

Shares of NYSE:GOOS opened at $37.63 on Friday. The company has a market cap of $4.12 billion, a price-to-earnings ratio of 36.89, a price-to-earnings-growth ratio of 1.19 and a beta of 3.13. The company has a 50-day moving average price of $40.59 and a 200-day moving average price of $42.11. The company has a current ratio of 3.38, a quick ratio of 0.76 and a debt-to-equity ratio of 1.47. Canada Goose Holdings Inc has a 12 month low of $31.67 and a 12 month high of $72.27.

Canada Goose (NYSE:GOOS) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.16) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.01. Canada Goose had a net margin of 15.60% and a return on equity of 41.47%. The firm had revenue of $71.10 million during the quarter, compared to the consensus estimate of $54.38 million. During the same period in the prior year, the firm posted ($0.16) earnings per share. The company’s quarterly revenue was up 59.1% compared to the same quarter last year. As a group, research analysts forecast that Canada Goose Holdings Inc will post 1.26 EPS for the current fiscal year.

Several analysts have weighed in on GOOS shares. DA Davidson downgraded shares of Canada Goose from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $48.00 to $42.00 in a research note on Thursday. Credit Suisse Group lowered their price target on shares of Canada Goose from $76.00 to $72.00 and set an “outperform” rating for the company in a research note on Thursday, August 15th. Finally, Zacks Investment Research downgraded shares of Canada Goose from a “buy” rating to a “hold” rating in a research note on Thursday. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $63.87.

Canada Goose Profile

Canada Goose Holdings Inc designs, manufactures, and sells premium outdoor apparel for men, women, youth, children, and babies. The company operates in two segments, Wholesale and Direct to Consumer. It offers parkas, jackets, shells, vests, knitwear, and accessories for fall, winter, and spring seasons.

Further Reading: Mutual Funds

Want to see what other hedge funds are holding GOOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Canada Goose Holdings Inc (NYSE:GOOS).

Institutional Ownership by Quarter for Canada Goose (NYSE:GOOS)

Receive News & Ratings for Canada Goose Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canada Goose and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.